• Reiterating the importance of a person-centric approach to developing new treatments and strengthening health systems in support of people living with dementias including Alzheimer’s Disease.
• Highlighting the progress countries have made since the 2023 G7 communiqué in Japan supported “policies and resources to care for people living with dementia,” including on early detection of Alzheimer’s disease and on the development of new therapeutics.
• Building consensus on the urgent need for sustained global collaboration toward healthy aging and brain health, including in addressing Alzheimer’s and dementia, supporting the realization of national plans, coordination, and knowledge sharing at the global level.

EBC looks forward to participating in this critical discussion: Frédéric Destrebecq, EBC’s Executive Director, will be speaking during the ‘Defining the Opportunities for Global Action’ panel alongside Chris Lynch (Alzheimer’s Disease International), Charlotte Refsum (Tony Blair Institute for Global Change), Wade Shen (Advanced Research Projects Agency for Health). The discussion will be moderated by George Vradenburg (Davos Alzheimer’s Collaborative) and will take place at 16:10-16:50 CEST. Panelists will be sharing insights on how we can enable countries to build sustained global collaboration toward healthy ageing and brain health.

The Davos Alzheimer’s Collaborative

The Davos Alzheimer’s Collaborative (DAC) is a pioneering worldwide initiative to cure Alzheimer’s disease and improve brain health, seeking to mirror the success of global efforts against infectious diseases such as HIV/AIDS, Covid, and Malaria. DAC is extending global research beyond its current focus on traditional Western European ethnic populations into the highly diversified populations of the Global South, where the vast majority of those with Alzheimer’s live. By introducing lower-cost screening and diagnostic tools as well as new treatment and prevention modalities in primary care and community health settings, DAC is driving implementation of health system solutions that are appropriate for worldwide application. DAC also promotes the vital importance of brain health throughout the lifespan by addressing cardiometabolic and lifestyle factors, especially in early and mid-life. Absent effective action at scale around the world, by 2050, more than 150 million families and half a billion people will be personally impacted by dementia, creating a social, financial, economic, and global security disaster of historic proportions. DAC was launched in Davos in 2021 by the World Economic Forum and the Global CEO Initiative on Alzheimer’s Disease.

Please note that requesting registration does not guarantee admission to the event. You will be notified by a member of the DAC team if your request is approved.